Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
12.41
-0.55 (-4.24%)
At close: Sep 2, 2025, 4:00 PM
12.17
-0.24 (-1.93%)
After-hours: Sep 2, 2025, 7:43 PM EDT

Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $25.40 million. The enterprise value is $19.83 million.

Market Cap25.40M
Enterprise Value 19.83M

Important Dates

The last earnings date was Monday, August 11, 2025, before market open.

Earnings Date Aug 11, 2025
Ex-Dividend Date n/a

Share Statistics

CVKD has 2.05 million shares outstanding. The number of shares has increased by 54.78% in one year.

Current Share Class 2.05M
Shares Outstanding 2.05M
Shares Change (YoY) +54.78%
Shares Change (QoQ) +6.38%
Owned by Insiders (%) 27.84%
Owned by Institutions (%) 7.34%
Float 1.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.79
P/TBV Ratio 5.91
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.56

Current Ratio 3.56
Quick Ratio 3.33
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -340.31% and return on invested capital (ROIC) is -216.88%.

Return on Equity (ROE) -340.31%
Return on Assets (ROA) -157.41%
Return on Invested Capital (ROIC) -216.88%
Return on Capital Employed (ROCE) -334.98%
Revenue Per Employee n/a
Profits Per Employee -$3.53M
Employee Count4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +62.97% in the last 52 weeks. The beta is 0.96, so CVKD's price volatility has been similar to the market average.

Beta (5Y) 0.96
52-Week Price Change +62.97%
50-Day Moving Average 11.83
200-Day Moving Average 15.16
Relative Strength Index (RSI) 50.36
Average Volume (20 Days) 32,112

Short Selling Information

The latest short interest is 17,823, so 0.87% of the outstanding shares have been sold short.

Short Interest 17,823
Short Previous Month 32,956
Short % of Shares Out 0.87%
Short % of Float 1.21%
Short Ratio (days to cover) 0.59

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -14.40M
Pretax Income -6.24M
Net Income -14.11M
EBITDA -14.39M
EBIT -14.40M
Earnings Per Share (EPS) -$8.62
Full Income Statement

Balance Sheet

The company has $5.57 million in cash and n/a in debt, giving a net cash position of $5.57 million or $2.72 per share.

Cash & Cash Equivalents 5.57M
Total Debt n/a
Net Cash 5.57M
Net Cash Per Share $2.72
Equity (Book Value) 4.30M
Book Value Per Share 2.14
Working Capital 4.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.67 million and capital expenditures -$9,788, giving a free cash flow of -$11.68 million.

Operating Cash Flow -11.67M
Capital Expenditures -9,788
Free Cash Flow -11.68M
FCF Per Share -$5.70
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -54.78%
Shareholder Yield -54.78%
Earnings Yield -55.54%
FCF Yield -45.97%

Analyst Forecast

The average price target for CVKD is $32.00, which is 157.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.00
Price Target Difference 157.86%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -22.18%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date Aug 20, 2024
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 1